Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVE: In most populations a greater proportion of men have hepatic steatosis than women. Sex-specific differences in hepatic dietary fatty acid (FA) metabolism have not been well characterized. We compared fasting and postprandial hepatic FA synthesis (de novo lipogenesis [DNL]) and oxidation in men and women. PARTICIPANTS AND METHODS: Fasting and postprandial hepatic FA metabolism was studied in 22 healthy men (n = 11) and women with similar age, body mass index, and liver fat content using metabolic substrates labeled with stable-isotope tracers ((2)H2O and [U(13)C]palmitate). Dietary FA oxidation was assessed by appearance of (13)C into plasma 3-hydroxybutyrate and breath CO2 as markers of liver and whole-body FA oxidation, respectively. RESULTS: Despite similar liver fat content, fasting and postprandial plasma triacylglycerol (TG) concentrations were significantly (P < .05) higher in men compared with women. The appearance of (13)C from dietary FA into plasma 3-hydroxybutyrate and breath CO2 was greater (P < .05) in women compared with men. Although the contribution of DNL into very low-density lipoprotein (VLDL)-TG was similar (∼ 10%) in the fasting state, there was a divergence in pattern over the course of the study, with men maintaining a higher contribution of DNL to VLDL-TG than women (P = .006 time x sex interaction). CONCLUSIONS: The combination of lower dietary FA oxidation and a prolonged increase in DNL observed in men may represent partitioning of FA into esterification and storage pathways within the liver, leading to greater VLDL-TG production, and predispose to the sex difference in hepatic steatosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, sexual dimorphism in lipid handling was observed, as women show high fatty acid oxidation and production of hydroxybutyrate but lower DNL compared to men matched for the same characteristics and liver fat content.40 In part, this explains why men have a higher prevalence of MASLD.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [40]
Citations
Cites
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 2×
“The prevalence of hepatic steatosis is higher in white men compared to white women (3, 4); the reasons for this remain unclear but will depend, to some degree on the balance between the availability and removal of FA in the liver.”
BackgroundVernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074 · cited 1×
“Risk factors for NAFLD include obesity and male gender (1, 2).”
BackgroundNordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058 · cited 1×
“Small, rather than large VLDL has been implicated in atherosclerosis progression (42).”
BackgroundChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775 · cited 3×
“Subjects were metabolically healthy, not taking medication known to affect lipid or glucose metabolism, were nonsmoking and consumed alcohol within the recommended limits (1).”
BackgroundLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 4×
“Liver fat content has been positively associated with fractional fasting DNL and VLDL-TG secretion from DNL in subjects (n 24) with and without liver fat (10).”
BackgroundInfluentialAdiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · cited 1×
“triacylglycerol (TG) and raised plasma TG concentrations (5, 6).”
BackgroundA possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.
McGarry, J. D., Mannaerts, G. P., & Foster, D. W. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108764 · Cited by 736 · cited 1×
“Rodent work has demonstrated an intermediate in the DNL pathway, malonyl-CoA is a potent inhibitor of carnitine palmitoyltransferase 1 which transports fatty acyl-CoA into the mitochondrion (38).”
BackgroundIntestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693 · cited 1×
“Additionally, we measured markers of cholesterol and bile acid metabolism as alterations in these have been implicated in NAFLD development (15, 16).”
MethodMin, H.-K., Kapoor, A., Fuchs, M., Mirshahi, F., Zhou, H., Maher, J., Kellum, J., Warnick, R., Contos, M. J., & Sanyal, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.004 · Cited by 652 · cited 2×
“Additionally, we measured markers of cholesterol and bile acid metabolism as alterations in these have been implicated in NAFLD development (15, 16).”
BackgroundMethodFabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Research works printed but not linked: 1
- Lifestyles Statistics Team, Health and Social Care Information Centre, 2015, Statistics on Obesity, Physical Activity, and Diet
Cited by
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610
“…evidence suggests impaired ketogenesis during the progression of steatohepatitis (Embade et al., 2016; Marinou et al., 2011; M€annistö et al., 2015; Pramfalk et al., 2015; Safaei et al., 2016), therapies that increase hepatic ketogenesis could prove salutary (Degirolamo et al., 2016; Honda et…”
BackgroundLonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T. A., Abdelmalek, M. F., & Suzuki, A. (2019) · Hepatology · doi:10.1002/hep.30626 · Cited by 1,050
“*See Pramfalk et al.(85) Abbreviations: ER, endoplasmic reticulum; mito., mitochondrial; TG, triglycerides. t a B l e 1 . p op ul at io n- B as ed S tu di es : S ex D iff er en ce s i n Fr eq ue nc y o f N a Fl D , F at ty l iv er , a nd N a Fl D F ib ro si s Re fe re nc e Co un try M /F (n ) Ag e (y ea rs ) Co ns id…”
Sex differences in metabolic regulation and diabetes susceptibility
Tramunt, B., Smati, S., Grandgeorge, N., Lenfant, F., Arnal, J.-F., Montagner, A., & Gourdy, P. (2020) · Diabetologia · doi:10.1007/s00125-019-05040-3 · Cited by 923
Mardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Räsänen, S. M., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 453
“We observed marked reductions in very-low-density lipoprotein (VLDL)-triglycerides (mean reduction 56.7%; Figure 1F) and in fasting plasma triglyceride concentrations (mean reduction 48.4%; Table S1) at the end of the study.”
InfluentialSexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver
Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00431-8 · Cited by 334
Metadata
- Authors
- Pramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L.
- Affiliations
- Oxford Centre for Diabetes, Endocrinology and Metabolism (GB)
- Churchill Hospital (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Hodson, Leanne
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-12-01
- Volume
- 100
- Issue
- 12
- Pages
- 4425-4433
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4667166
- OpenAlex
- W2189728293
- Cited by
- 138
- References
- 46
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 10 · 2023: 12 · 2022: 19 · 2021: 17 · 2020: 18 · 2019: 14 · 2018: 11 · 2017: 9 · 2016: 7
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0512-10005)
- British Heart Foundation (FS/11/18/28633)
- NIHR BioResource
- Science and Technology Facilities Council (ST/J00149X/1)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- sex differences, non-alcoholic fatty liver disease, hepatic steatosis, de novo lipogenesis, fatty acid oxidation, hepatic fatty acid metabolism, beta-hydroxybutyrate, postprandial lipemia, plasma triglycerides
- MeSH terms
- Adult, Aged, Carbon Dioxide, Dietary Fats, Fasting, Fatty Acids, Female, Humans, Lipids, Lipoproteins, VLDL, Liver, Male, Middle Aged, Oxidation-Reduction, Palmitates, Sex Characteristics, Triglycerides, Postprandial Period, 3-Hydroxybutyric Acid, Lipogenesis, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men. https://app.cochat.ai/papers/10.1210/jc.2015-2649
- The paper
- Pramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L. (2015). Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2015-2649
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.